Clinical Trial Update: Radiopaque Hydrogel in Patients Undergoing Radiotherapy for Pancreatic Cancer [NA]

View source ↗

Summary

A clinical trial evaluating a radiopaque hydrogel used during radiotherapy for pancreatic adenocarcinoma has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Radiopaque hydrogel

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Pancreatic Adenocarcinoma | NA | Status: COMPLETED | Results posted: 2022-12-21